Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (CN105705509) 4-{4-[(1 e)-4-(2,9-diazaspiro[5.5]undec-2-yl)but-1 -en-1 -yl]-2-methylbenzyl}-5-(propan-2-yl)-1 h-pyrazol-3-yl beta-d- glucopyranoside acetate

Office : China
Application Number: 201480060924.9 Application Date: 30.10.2014
Publication Number: 105705509 Publication Date: 22.06.2016
Grant Number: 105705509 Grant Date: 04.12.2018
Publication Kind : B
Prior PCT appl.: Application Number:PCTUS2014063161 ; Publication Number:2015069541 Click to see the data
IPC:
C07H 17/02
A61K 31/7056
A61P 3/10
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
H
SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
17
Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
02
Heterocyclic radicals containing only nitrogen as ring hetero atoms
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
7042
Compounds having saccharide radicals and heterocyclic rings
7052
having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
7056
containing five-membered rings with nitrogen as a ring hetero atom
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3
Drugs for disorders of the metabolism
08
for glucose homeostasis
10
for hyperglycaemia, e.g. antidiabetics
CPC:
C07H 17/02
Applicants: ELI LILLY AND COMPANY
伊莱利利公司
Inventors: REUTZEL-EDENS SUSAN MARIE
S·M·雷乌特泽尔-埃登斯
Agents: 北京市中咨律师事务所 11247
北京市中咨律师事务所 11247
Priority Data: 61/901,488 08.11.2013 US
Title: (EN) 4-{4-[(1 e)-4-(2,9-diazaspiro[5.5]undec-2-yl)but-1 -en-1 -yl]-2-methylbenzyl}-5-(propan-2-yl)-1 h-pyrazol-3-yl beta-d- glucopyranoside acetate
(ZH) 为SGLT1抑制剂的吡唑化合物的乙酸盐
Abstract:
(EN) The present invention provides a compound of Formula I or hydrate thereof, useful for the treatment of diabetes.
(ZH) 本发明提供可用于治疗糖尿病的式I化合物或其水合物。
Also published as:
UAa201603973CA2925128DOP2016000067IL244899US20160215011KR1020160067157
EA201690749EP3066108AU2014347065ID2017/05727MYPI 2016701635PH1/2016/500851
VN48279MA39019BR112016008428JP6197113TH170175IN201627009884
TN2016000112ES2703944WO/2015/069541